Evidence map›Paper›PMID 38958148›Full record

ArticleJournal of the American Heart Association2024

Coronary Artery Disease Is A Stronger Predictor of All-Cause Mortality Than Left Ventricular Ejection Fraction Among Patients With Newly Diagnosed Heart Failure: Insights From the WDHR.

Roni Ranghoej Nielsen, Kasper Pryds, Kevin Kris Warnakula Olesen, Martin Bødtker Mortensen, Christine Gyldenkerne, Jens Cosedis Nielsen, Gerhard Hindricks, Nikolaos Dagres, Michael Maeng

Abstract read
In one paragraph

Article in Journal of the American Heart Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Impact of Heart Failure and Chronic Kidney Disease on All-Cause Mortality in Patients Undergoing Coronary Angiography: Results From the Finnish Kardio Multicentre Registry.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2025
    Article
  3. Observational
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Roni Ranghoej NielsenDepartment of Cardiology Aarhus University Hospital Aarhus Denmark.ORCID 0000-0001-9228-3869
Kasper PrydsDepartment of Cardiology Aarhus University Hospital Aarhus Denmark.ORCID 0000-0003-0182-8718
Kevin Kris Warnakula OlesenDepartment of Cardiology Aarhus University Hospital Aarhus Denmark.ORCID 0000-0002-0560-3615
Martin Bødtker MortensenDepartment of Cardiology Aarhus University Hospital Aarhus Denmark.
Christine GyldenkerneDepartment of Cardiology Aarhus University Hospital Aarhus Denmark.ORCID 0000-0001-5904-7063
Jens Cosedis NielsenDepartment of Cardiology Aarhus University Hospital Aarhus Denmark.ORCID 0000-0001-9414-1653
Gerhard HindricksGerman Heart Center Charité Berlin Germany.ORCID 0000-0002-0132-0773
Nikolaos DagresGerman Heart Center Charité Berlin Germany.ORCID 0000-0003-0323-4956
Michael MaengDepartment of Cardiology Aarhus University Hospital Aarhus Denmark.ORCID 0000-0002-4310-6433

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn patients with newly diagnosed heart failure (HF) and left ventricular ejection fraction (LVEF) <50%, little is known whether LVEF per se or presence of coronary artery disease (CAD) provides independent prognostic information on all-cause mortality. METHODS AND

resultsUsing the WDHR (Western Denmark Heart Registry), we identified 3620 patients with newly diagnosed HF and LVEF 10% to 49% referred for first-time coronary angiography as part of general workup of HF. Patients were stratified by LVEF (10%-35% versus 36%-49%) and presence of CAD. We estimated 10-year all-cause mortality risk and calculated hazard ratios adjusted for relevant comorbidities and risk factors (aHRs). CAD was present in 1592 (44%) patients. Lower LVEF was associated with a relative 15% increased 10-year mortality: 37% for LVEF 36% to 49% versus 42% for LVEF 10% to 35% (aHR, 1.15 [95% CI, 0.99-1.34]). This result did not change when stratified into those with CAD (52% versus 56%; aHR, 1.11 [95% CI, 0.91-1.35]) and those without CAD (27% versus 33%; aHR, 1.24 [95% CI, 0.97-1.57]). In comparison, presence and extent of CAD were associated with a relative 43% increased 10-year mortality (CAD versus no CAD, 55.0% versus 31.5%; aHR, 1.43 [95% CI, 1.25-1.64]). Compared with a matched general population, excess mortality risk was higher for patients with HF and CAD (54.7% versus 26.3%; aHR, 2.10 [95% CI, 1.85-2.39]) versus those with HF and no CAD (31.4% versus 17.2%; aHR, 1.76 [95% CI, 1.52-2.02]).

conclusionsAmong newly diagnosed patients with HF and LVEF <50%, presence and extent of CAD are associated with substantial higher all-cause mortality risk than lower LVEF.

Indexed as

Coronary Artery DiseaseHeart FailureRegistriesStroke VolumeVentricular Function, LeftAgedAged, 80 and overCause of DeathCoronary AngiographyDenmarkFemaleHumansMaleMiddle AgedPrognosisRisk Assessmentcoronary artery diseaseheart failureleft ventricular ejection fraction

Identifiers

PMID38958148
PMCPMC11292771

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.